ACOTEC SCIEN.H. DL-00001 (F:7W3) — Market Cap & Net Worth
Market Cap & Net Worth: ACOTEC SCIEN.H. DL-00001 (7W3)
ACOTEC SCIEN.H. DL-00001 (F:7W3) has a market capitalization of $198.13 Million (€169.47 Million) as of September 20, 2026. Listed on the F stock exchange, this Germany-based company holds position #16681 globally and #1574 in its home market, demonstrating a 4.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ACOTEC SCIEN.H. DL-00001's stock price €0.63 by its total outstanding shares 313389171 (313.39 Million). Also see ACOTEC SCIEN.H. DL-00001 asset portfolio for a full breakdown of the balance sheet.
ACOTEC SCIEN.H. DL-00001 Market Cap History: 2021 to 2026
ACOTEC SCIEN.H. DL-00001's market capitalization history from 2021 to 2026. Data shows change from $439.66 Million to $230.82 Million (-19.86% CAGR). Also see ACOTEC SCIEN.H. DL-00001 cash flow conversion for how efficiently the company converts equity into cash flow.
ACOTEC SCIEN.H. DL-00001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ACOTEC SCIEN.H. DL-00001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest ACOTEC SCIEN.H. DL-00001 stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.81x
ACOTEC SCIEN.H. DL-00001's market cap is 0.81 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.40x
ACOTEC SCIEN.H. DL-00001's market cap is 4.40 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $439.66 Million | $303.81 Million | -$79.08 Million | 1.45x | N/A |
| 2022 | $732.77 Million | $395.55 Million | $70.14 Million | 1.85x | 10.45x |
| 2023 | $450.65 Million | $473.85 Million | $14.49 Million | 0.95x | 31.11x |
| 2024 | $265.63 Million | $533.99 Million | $52.28 Million | 0.50x | 5.08x |
| 2025 | $523.93 Million | $644.63 Million | $119.18 Million | 0.81x | 4.40x |
Competitor Companies of 7W3 by Market Capitalization
Companies near ACOTEC SCIEN.H. DL-00001 in the global market cap rankings as of September 20, 2026. Review 7W3 tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to ACOTEC SCIEN.H. DL-00001 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
ACOTEC SCIEN.H. DL-00001 Historical Marketcap From 2021 to 2026
Between 2021 and today, ACOTEC SCIEN.H. DL-00001's market cap moved from $439.66 Million to $ 230.82 Million, with a yearly change of -19.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €230.82 Million | -55.94% |
| 2025 | €523.93 Million | +97.24% |
| 2024 | €265.63 Million | -41.06% |
| 2023 | €450.65 Million | -38.50% |
| 2022 | €732.77 Million | +66.67% |
| 2021 | €439.66 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of ACOTEC SCIEN.H. DL-00001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $198.13 Million USD |
| MoneyControl | $198.13 Million USD |
| MarketWatch | $198.13 Million USD |
| marketcap.company | $198.13 Million USD |
| Reuters | $198.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ACOTEC SCIEN.H. DL-00001
Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China and internationally. The company's products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease with… Read more